Cold plasma treatment for biomedical applications: using aluminum foam to reduce risk while increasing efficacy
Zhitong Chen, Richard Obenchain, Richard E. Wirz

TL;DR
This study explores using aluminum foam as an intermediary in cold plasma treatments to enhance reactive species delivery and safety in biomedical applications, especially surgery, by filtering sparks and increasing treatment efficacy.
Contribution
It introduces aluminum foam with specific pore size as a novel method to improve cold plasma therapy safety and effectiveness in clinical settings.
Findings
Al foam filters sparks to prevent tissue damage during plasma treatment.
10 PPI Al foam increases reactive species concentration in plasma.
Enhanced cell killing efficiency with Al foam in melanoma treatment.
Abstract
Plasma medicine is an emerging and innovative interdisciplinary research field combining biology, chemistry, physics, engineering, and medicine. However, the safe clinical application of cold atmospheric plasma (CAP) technology is still a challenge. Here, we examine the use of aluminum (Al) foam with three pores-per-inch (PPI) ratings in clinical plasma applications. Al foams can filter sparks to avoid damage from high voltage discharge during surgery and efficiently deliver reactive species generated in CAP to the target. The sparks appear and plasma intensity increases at the foam/discharge interface, which just slightly increases the interface temperature without changing the interface microstructure during a 30-minute treatment. After CAP penetrated the Al foams, N2, N2+, *OH, O, and He emission peaks were characterized, and the highest values appeared using Al foams with 10 PPI.…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPlasma Applications and Diagnostics
